Log in to save to my catalogue

Effect of hemoadsorption during cardiopulmonary bypass surgery - a blinded, randomized, controlled p...

Effect of hemoadsorption during cardiopulmonary bypass surgery - a blinded, randomized, controlled p...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4826492

Effect of hemoadsorption during cardiopulmonary bypass surgery - a blinded, randomized, controlled pilot study using a novel adsorbent

About this item

Full title

Effect of hemoadsorption during cardiopulmonary bypass surgery - a blinded, randomized, controlled pilot study using a novel adsorbent

Publisher

England: BioMed Central Ltd

Journal title

Critical care (London, England), 2016-04, Vol.20 (1), p.96-96, Article 96

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Cardiopulmonary bypass (CPB) surgery initiates a systemic inflammatory response, which is associated with postoperative morbidity and mortality. Hemoadsorption (HA) of cytokines may suppress inflammatory responses and improve outcomes. We tested a new sorbent used for HA (CytoSorb™; CytoSorbents Europe GmbH, Berlin, Germany) installed in the CPB ci...

Alternative Titles

Full title

Effect of hemoadsorption during cardiopulmonary bypass surgery - a blinded, randomized, controlled pilot study using a novel adsorbent

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4826492

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4826492

Other Identifiers

ISSN

1364-8535

E-ISSN

1466-609X,1364-8535,1366-609X

DOI

10.1186/s13054-016-1270-0

How to access this item